Latest Internal Medicine News
Q&A: How Can Understanding Antibodies Further the Fight Against Covid-19?
- September 22, 2021Source: healthline
These Groups Are at Higher Risk of Developing Long COVID-19
- September 22, 2021Source: Everyday Health
Craft beers are tasty, but they can be a shortcut to a hangover or worse if you’re not careful.
- September 21, 2021Source: Yale News
How nations can best allocate COVID-19 vaccines remains a discussion of global importance. And at its heart is the question of whether countries with greater access to vaccines should focus on vaccinating their own citizens or sharing their vaccine allotments with other nations.
- September 21, 2021Source: NPR
Johnson & Johnson says a booster six months after the first shot increases antibodies 12-fold, indicating a second shot would provide added protection.
- September 20, 2021Source: YaleNews
Two Yale-led studies suggest that a standard measurement designed to help predict which patients have the best chances of survival—and who therefore should receive treatment—could promote racial disparities of treatment outcomes.
- September 20, 2021Source: NPR
Alcohol Use Disorder in Women
- September 20, 2021
The Yale Black Postdoctoral Association is about community and support, said the founders, but it is also about enhancing the visibility of Black postdocs — to one another, and to the Yale School of Medicine community at large.
- September 20, 2021Source: verywell
How to Sober Up: What Actually Works?
- September 19, 2021
Yale Cancer Center Study Finds New Drug Combination Shows Clinical Activity for Patients with Prostate Cancer
New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC).